Non Invasive Cancer Test (NICT): a Proof of Principle Study.
NCT ID: NCT03019471
Last Updated: 2025-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40 participants
OBSERVATIONAL
2016-03-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120
Detection of Tumor DNA in Blood Samples From Cancer Patients
NCT02288754
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
NCT01441089
Cell-free DNA in Hereditary And High-Risk Malignancies 1
NCT04261972
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT02688517
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lung cancer
Isolate Tumor DNA from the patients blood.
Isolation of tumor DNA
Breast cancer
Isolate Tumor DNA from the patients blood.
Isolation of tumor DNA
Colorectal cancer
Isolate Tumor DNA from the patients blood.
Isolation of tumor DNA
Glioma
Isolate Tumor DNA from the patients blood.
Isolation of tumor DNA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Isolation of tumor DNA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients age \> 18 years, willing and able to comply with the protocol as judged by the investigator with a signed informed consent
Exclusion Criteria
2. Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christine C. De Die-Smulders, Prof. dr.
Role: PRINCIPAL_INVESTIGATOR
Clinical Geneticist in MUMC+
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University Medical Center
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL55080.068.15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.